PRESILIUM PRIVATE WEALTH, LLC

Position in MRK — Merck & Co., Inc.

CIK 1939831 RADNOR, PA

Position in MRK

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$653,294

+$247,436 QoQ

Shares Held

5,084

+50.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

2.49%

of 13F equity value

Holder Rank

#2,464

of 3,769 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

PRESILIUM PRIVATE WEALTH, LLC holds $3,143,394 across 6 Drug Manufacturers - General names. MRK ranks #3 (20.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	4,342	$823,330
2	NVS	Novartis AG	4,603	$721,382
3	MRK	Merck & Co., Inc. This page	5,084	$653,294
4	GSK	GSK plc	6,852	$359,181
5	LLY	ELI LILLY & Co	290	$347,834
6	BMY	Bristol Myers Squibb Co	4,137	$238,373

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$653,294	5,084	+50.7%	Shares	Sole	2026-07-22
2026-03-31	$405,858	3,374	-27.4%	Shares	Sole	2026-04-17
2025-12-31	$489,353	4,649	0.0%	Shares	Sole	2026-01-13
2025-09-30	$390,190	4,649	-3.8%	Shares	Sole	2025-10-21
2025-06-30	$382,659	4,834	+37.3%	Shares	Sole	2025-07-25
2025-03-31	$315,955	3,520	-1.4%	Shares	Sole	2025-04-10
2024-12-31	$355,143	3,570	0.0%	Shares	Sole	2025-01-14
2024-09-30	$405,409	3,570	-18.0%	Shares	Sole	2024-10-03
2024-06-30	$538,777	4,352	-18.0%	Shares	Sole	2024-07-15
2024-03-31	$700,258	5,307	+17.0%	Shares	Sole	2024-05-01
2023-12-31	$494,623	4,537	-9.6%	Shares	Sole	2024-01-10
2023-09-30	$516,603	5,018	-16.7%	Shares	Sole	2023-10-10
2023-06-30	$695,340	6,026	-8.7%	Shares	Sole	2023-07-21
2023-03-31	$701,961	6,598	+10.0%	Shares	Sole	2023-04-20
2022-12-31	$665,700	6,000	—	Shares	Sole	2023-02-08
No filing history on record for this holder in this stock.